NCT05135455View on ClinicalTrials.gov

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIA

CompletedOBSERVATIONAL
Enrollment

467

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Prevention of Infectious Disease Caused by SARS-CoV-2
Trial Locations (6)

Unknown

Research Site, Chiba

Research Site, Hyōgo

Research Site, Kumamoto

Research Site, Mie

Research Site, Shizuoka

Research Site, Tokyo

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY